Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -122.91% |
| Q3 2025 | 770.50% |
| Q2 2025 | 60.05% |
| Q1 2025 | -218.48% |
| Q4 2024 | 44.66% |
| Q3 2024 | -60.58% |
| Q2 2024 | 52.58% |
| Q1 2024 | 26.54% |
| Q4 2023 | 38.34% |
| Q3 2023 | -13.82% |
| Q2 2023 | 31.21% |
| Q1 2023 | -6.72% |
| Q4 2022 | -7.27% |
| Q3 2022 | -2.90% |
| Q2 2022 | -15.21% |
| Q1 2022 | -44.30% |
| Q4 2021 | 30.16% |
| Q3 2021 | 34.12% |
| Q2 2021 | -55.94% |
| Q1 2021 | -195.75% |
| Q4 2020 | 200.44% |
| Q3 2020 | -12.16% |
| Q2 2020 | -16.93% |
| Q1 2020 | 6.75% |
| Q4 2019 | -51.46% |
| Q3 2019 | -10.20% |
| Q2 2019 | -30.47% |
| Q1 2019 | -30.79% |
| Q4 2018 | -3.89% |
| Q3 2018 | -6.93% |
| Q2 2018 | -56.19% |
| Q1 2018 | -19.15% |
| Q4 2017 | -55.26% |
| Q3 2017 | 4.48% |
| Q2 2017 | -34.03% |
| Q1 2017 | -35.53% |
| Q4 2016 | 7.67% |
| Q3 2016 | -8.21% |
| Q2 2016 | 0.00% |
| Q1 2016 | 4.02% |